NSE BSE
advanced enzyme tech ltd stock

ADVANCED ENZYME TECH LTD Share Price

- - (%)
- NSE: ADVENZYMES

ADVANCED ENZYME TECH LTD Share Price Update

As of the latest trading session, ADVANCED ENZYME TECH LTD share price is currently at 380, which is up by 3.60 from its previous closing. Today, the stock has fluctuated between 368.60 and 386.00. Over the past year, ADVANCED ENZYME TECH LTD has achieved a return of 32.07 %. In the last month alone, the return has been 3.99 %. Read More...

ADVANCED ENZYME TECH LTD Performance

Day Range

Low368.60 High386.00
378.60

52 Week Range

Low 280.00 High 425.15
378.60

ADVANCED ENZYME TECH LTD Share Price

18039

540025

ADVENZYMES

img img img img
No Data Available

Open Price

376.80

Prev. Close

376.40

Volume (Shares)

253392.00

Total traded value

959.34

Upper Circuit

451.65

Lower Circuit

301.15

Note: The current prices & values are delayed, Login to your account for live updates.

ADVANCED ENZYME TECH LTD Fundamentals


(Standalone)

Market Cap (Cr) 4249.31
PE Ratio (TTM) 38.87
Book Value / Share 51.90
Beta 0.63
ROE 22.29%
EPS (TTM) 11.02
Dividend Yield 1.36%
Net Profit Qtr (Cr) 3.14

ADVANCED ENZYME TECH LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 92.40
Operating Expense 66.28
Net Profit 3.14
Net Profit Margin (%) 3.39
Earnings Per Share (EPS) 0.28
EBITDA 13.51
Effective Tax Rate (%) 69.77
Particulars DEC 2023 (Values in Cr)
Revenue 91.14
Operating Expense 69.35
Net Profit 19.12
Net Profit Margin (%) 20.97
Earnings Per Share (EPS) 1.71
EBITDA 28.11
Effective Tax Rate (%) 24.60
Particulars SEP 2023 (Values in Cr)
Revenue 96.58
Operating Expense 72.60
Net Profit 18.38
Net Profit Margin (%) 19.03
Earnings Per Share (EPS) 1.64
EBITDA 27.40
Effective Tax Rate (%) 25.76
Particulars JUN 2023 (Values in Cr)
Revenue 85.35
Operating Expense 63.12
Net Profit 67.49
Net Profit Margin (%) 79.07
Earnings Per Share (EPS) 6.04
EBITDA 76.03
Effective Tax Rate (%) 8.16
Particulars MAR 2023 (Values in Cr)
Revenue 82.56
Operating Expense 62.10
Net Profit 17.50
Net Profit Margin (%) 21.19
Earnings Per Share (EPS) 1.56
EBITDA 26.10
Effective Tax Rate (%) 24.82
Particulars MAR 2024 (Values in Cr)
Revenue 365.47
Operating Expense 271.34
Net Profit 108.12
Net Profit Margin (%) 29.58
Earnings Per Share (EPS) 9.67
EBITDA 145.05
Effective Tax Rate (%) 19.30
Particulars MAR 2023 (Values in Cr)
Revenue 311.53
Operating Expense 247.05
Net Profit 55.53
Net Profit Margin (%) 17.82
Earnings Per Share (EPS) 4.97
EBITDA 84.70
Effective Tax Rate (%) 25.24
Particulars MAR 2022 (Values in Cr)
Revenue 272.80
Operating Expense 209.81
Net Profit 54.51
Net Profit Margin (%) 19.98
Earnings Per Share (EPS) 4.88
EBITDA 81.72
Effective Tax Rate (%) 24.36
Particulars MAR 2021 (Values in Cr)
Revenue 283.47
Operating Expense 191.87
Net Profit 71.01
Net Profit Margin (%) 25.05
Earnings Per Share (EPS) 6.36
EBITDA 107.54
Effective Tax Rate (%) 27.85
Particulars MAR 2020 (Values in Cr)
Revenue 247.35
Operating Expense 180.50
Net Profit 57.96
Net Profit Margin (%) 23.43
Earnings Per Share (EPS) 5.19
EBITDA 85.75
Effective Tax Rate (%) 23.59
Particulars MAR 2024 (Values in Cr)
Book Value / Share 118.41
ROE % 10.70
ROCE % 14.53
Total Debt to Total Equity 0.03
EBITDA Margin 36.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 110.45
ROE % 8.94
ROCE % 12.02
Total Debt to Total Equity 0.03
EBITDA Margin 33.09
Particulars MAR 2022 (Values in Cr)
Book Value / Share 97.37
ROE % 12.02
ROCE % 16.38
Total Debt to Total Equity 0.03
EBITDA Margin 39.48
Particulars MAR 2021 (Values in Cr)
Book Value / Share 86.90
ROE % 16.71
ROCE % 22.70
Total Debt to Total Equity 0.03
EBITDA Margin 48.11
Particulars MAR 2020 (Values in Cr)
Book Value / Share 75.18
ROE % 17.52
ROCE % 22.99
Total Debt to Total Equity 0.04
EBITDA Margin 47.08
Particulars MAR 2024 (Values in Cr)
Book Value / Share 51.91
ROE % 22.29
ROCE % 27.61
Total Debt to Total Equity 0.00
EBITDA Margin 44.93
Particulars MAR 2023 (Values in Cr)
Book Value / Share 46.98
ROE % 11.04
ROCE % 14.76
Total Debt to Total Equity 0.00
EBITDA Margin 27.25
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.97
ROE % 11.90
ROCE % 15.71
Total Debt to Total Equity 0.00
EBITDA Margin 30.02
Particulars MAR 2021 (Values in Cr)
Book Value / Share 38.97
ROE % 17.62
ROCE % 23.93
Total Debt to Total Equity 0.01
EBITDA Margin 37.98
Particulars MAR 2020 (Values in Cr)
Book Value / Share 33.17
ROE % 16.80
ROCE % 21.12
Total Debt to Total Equity 0.04
EBITDA Margin 34.75
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 143.49
Total Assets 1535.46
Total Liabilities 1535.46
Total Equity 1371.08
Share Outstanding 111824075
Price to Book Ratio 6.69
Return on Assets (%) 8.68
Return on Capital (%) 9.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 123.34
Total Assets 1421.84
Total Liabilities 1421.84
Total Equity 1284.17
Share Outstanding 111824075
Price to Book Ratio 4.93
Return on Assets (%) 7.42
Return on Capital (%) 8.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 273.63
Total Assets 1267.60
Total Liabilities 1267.60
Total Equity 1140.38
Share Outstanding 111800675
Price to Book Ratio 6.57
Return on Assets (%) 9.43
Return on Capital (%) 10.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 197.77
Total Assets 1156.17
Total Liabilities 1156.17
Total Equity 1032.62
Share Outstanding 111728425
Price to Book Ratio 8.85
Return on Assets (%) 12.62
Return on Capital (%) 13.88
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 83.02
Total Assets 978.60
Total Liabilities 978.60
Total Equity 867.44
Share Outstanding 111678475
Price to Book Ratio 4.32
Return on Assets (%) 13.21
Return on Capital (%) 14.62
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 18.56
Total Assets 632.93
Total Liabilities 632.93
Total Equity 580.47
Share Outstanding 111824075
Price to Book Ratio 6.69
Return on Assets (%) 17.08
Return on Capital (%) 18.63
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 24.72
Total Assets 575.80
Total Liabilities 575.80
Total Equity 525.33
Share Outstanding 111824075
Price to Book Ratio 4.93
Return on Assets (%) 9.64
Return on Capital (%) 10.57
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 17.97
Total Assets 529.62
Total Liabilities 529.62
Total Equity 480.35
Share Outstanding 111800675
Price to Book Ratio 6.57
Return on Assets (%) 10.29
Return on Capital (%) 11.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.87
Total Assets 489.60
Total Liabilities 489.60
Total Equity 435.44
Share Outstanding 111728425
Price to Book Ratio 8.85
Return on Assets (%) 14.50
Return on Capital (%) 16.27
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.02
Total Assets 422.67
Total Liabilities 422.67
Total Equity 370.48
Share Outstanding 111678475
Price to Book Ratio 4.32
Return on Assets (%) 13.71
Return on Capital (%) 15.29
Particulars MAR 2024 (Values in Cr)
Net Income 187.82
Cash from Operations 190.60
Cash from Investing -64.64
Cash from Financing -59.23
Net change in Cash 17.48
Free Cash Flow 237.86
Particulars MAR 2023 (Values in Cr)
Net Income 140.38
Cash from Operations 177.00
Cash from Investing -298.18
Cash from Financing -25.79
Net change in Cash -183.61
Free Cash Flow 215.10
Particulars MAR 2022 (Values in Cr)
Net Income 171.05
Cash from Operations 176.82
Cash from Investing -3.78
Cash from Financing -48.50
Net change in Cash 70.00
Free Cash Flow 204.93
Particulars MAR 2021 (Values in Cr)
Net Income 210.13
Cash from Operations 219.67
Cash from Investing -26.03
Cash from Financing -26.38
Net change in Cash 110.54
Free Cash Flow 239.12
Particulars MAR 2020 (Values in Cr)
Net Income 179.15
Cash from Operations 191.79
Cash from Investing -44.49
Cash from Financing -38.55
Net change in Cash 57.84
Free Cash Flow 242.44
Particulars MAR 2024 (Values in Cr)
Net Income 133.99
Cash from Operations 83.01
Cash from Investing -6.88
Cash from Financing -56.88
Net change in Cash -7.95
Free Cash Flow 103.62
Particulars MAR 2023 (Values in Cr)
Net Income 74.27
Cash from Operations 66.75
Cash from Investing -42.35
Cash from Financing -11.99
Net change in Cash -4.04
Free Cash Flow 90.17
Particulars MAR 2022 (Values in Cr)
Net Income 72.07
Cash from Operations 58.54
Cash from Investing -14.23
Cash from Financing -10.87
Net change in Cash 11.99
Free Cash Flow 69.08
Particulars MAR 2021 (Values in Cr)
Net Income 98.42
Cash from Operations 111.05
Cash from Investing -69.90
Cash from Financing -15.48
Net change in Cash -1.16
Free Cash Flow 120.52
Particulars MAR 2020 (Values in Cr)
Net Income 75.85
Cash from Operations 58.67
Cash from Investing -24.93
Cash from Financing -18.55
Net change in Cash 2.48
Free Cash Flow 99.52
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCED ENZYME TECH LTD 375.85 29.16 3.17 4202.91 280.95 / 425.10
BLISS GVS PHARMA LTD 115.55 12.63 1.25 1210.24 77.65 / 148.95
CIPLA LTD 1511.95 28.67 4.57 122092.68 1018.30 / 1581.70
FERMENTA BIOTECH LIMITED 198.30 0.00 2.01 583.62 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2570.85 66.33 24.49 43551.75 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCED ENZYME TECH LTD 375.85 34.11 7.24 4202.91 280.95 / 425.10
AMRUTAJAN HEALTH LTD 751.75 48.31 7.53 2173.36 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6756.05 112.98 23.72 16890.13 3715.05 / 7550.00
BLISS GVS PHARMA LTD 115.55 15.89 1.22 1210.24 77.65 / 148.95
ABBOTT INDIA LIMITED 27481.60 48.62 15.78 58398.40 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 384.30
  • 26 Days 377.90
  • 10 Days 384.00
  • 50 Days 380.80
  • 12 Days 382.90
  • 100 Days 381.20
  • 20 Days 383.40
  • 200 Days 328.60
382.30
PIVOT
First Resistance 385.55
Second Resistance 389.65
Third Resistance 392.90
First Support 378.20
Second Support 374.95
Third Support 370.85
RSI 46.02
MACD 5.02
Commodity Channel Index (CCI) -52.87
ADX 35.03
Williams % R -74.75

Over 1 Month

down

3.99

Over 3 Months

down

3.66

Over 6 Months

down

3.13

Over 1 Year

down

32.07

Over 3 Years

down

-2.35

Over 5 Years

down

18.54

ADVANCED ENZYME TECH LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ADVANCED ENZYME TECH LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
27.99
Promoter Holdings
43.49
FII
23.01
DII
5.49
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Vasant Rathi Shareholding of Promoter and Promoter Group 3.7053702E7 33.14
Orbimed Asia Iii Mauritius Limited Public Shareholding 1.1053245E7 9.88
Nalanda India Equity Fund Limited Public Shareholding 9963685.0 8.91
Hdfc Small Cap Fund Public Shareholding 4101432.0 3.67
Rasika Vasant Rathi Shareholding of Promoter and Promoter Group 2665825.0 2.38
Reshma Namita Rathi Shareholding of Promoter and Promoter Group 2646858.0 2.37
Rachana Vasant Rathi Shareholding of Promoter and Promoter Group 2641500.0 2.36
Orbimed Asia Iii Mauritius Fvci Limited Public Shareholding 2456277.0 2.2
Pradip Bhailal Shah Public Shareholding 2021400.0 1.81
Icici Prudential Esg Fund Public Shareholding 1974513.0 1.77
Mukund Madhusudan Kabra Public Shareholding 1823000.0 1.63
Kishor Laxminarayan Rathi Shareholding of Promoter and Promoter Group 1466000.0 1.31
Clarus Capital I Public Shareholding 1433996.0 1.28
Prabhavati Vasant Rathi Shareholding of Promoter and Promoter Group 913000.0 0.82
Madhusudan Kabra Shareholding of Promoter and Promoter Group 715600.0 0.64
Advanced Vital Enzymes Pvt Ltd Shareholding of Promoter and Promoter Group 487609.0 0.44
Chandrakumar Laxminarayan Rathi Shareholding of Promoter and Promoter Group 46500.0 0.04
Atharva Green Ecotech Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Piyush Chandrakumar Rathi Shareholding of Promoter and Promoter Group 0.0 0.0
Radhika Ashish Pujara Shareholding of Promoter and Promoter Group 0.0 0.0
Savita Chandrakumar Rathi Shareholding of Promoter and Promoter Group 0.0 0.0

ADVANCED ENZYME TECH LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-08-04 1.0 Final 2023-08-05 Equity shares 2023-05-19 4.0 Interim 2023-05-20 Equity shares 2022-08-11 1.0 Final 2022-08-12 Equity shares 2021-08-31 0.9 Final 2021-09-01 Equity shares 2020-07-09 0.6 Final 2020-07-11 Equity shares 2019-08-01 0.6 Final 2019-08-03 Equity shares 2018-09-06 0.5 Final 2018-09-08 Equity shares 2017-09-04 0.4 Final 2017-09-06 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2017-05-25 10.0 2.0 2017-05-26

Learn More About Stocks

About ADVANCED ENZYME TECH LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ADVANCED ENZYME TECH LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Advanced Enzyme Technologies Ltd?

Answer Field

The share price of Advanced Enzyme Technologies Ltd for NSE is ₹ 380 and for BSE is ₹ 380.1.

What is the Market Cap of Advanced Enzyme Technologies Ltd?

Answer Field

The market cap of Advanced Enzyme Technologies Ltd for NSE is ₹ 4,249.31 Cr. and for BSE is ₹ 4,250.43 Cr. as of now.

What is the 52 Week High and Low of Advanced Enzyme Technologies Ltd?

Answer Field

The 52 Week High and Low of Advanced Enzyme Technologies Ltd for NSE is ₹ 425.15 and ₹ 280.00 and for BSE is ₹ 425.10 and ₹ 280.95.

How to Buy Advanced Enzyme Technologies Ltd share?

Answer Field

You can trade in Advanced Enzyme Technologies Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Advanced Enzyme Technologies Ltd?

Answer Field

The 1 year returns on the stock has been 32.07%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader